A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer

Clinical trial NCT01636284 · COMPLETED

Trial details

NCT number: NCT01636284
Sponsor: Jennerex Biotherapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carinoma

Start date: 2012-06-01
Primary completion: 2013-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.